Zhang G - Search Results

1

Multifunctional small-molecule theranostic agents for tumor-specific imaging and targeted chemotherapy.

Zhang R, Hao L, Chen P, Zhang G, Liu N. Zhang R, et al. Among authors: zhang g. Bioorg Chem. 2023 Aug;137:106576. doi: 10.1016/j.bioorg.2023.106576. Epub 2023 May 3. Bioorg Chem. 2023. PMID: 37182421 Review.

2

One shoot, three birds: Targeting NEK2 orchestrates chemoradiotherapy, targeted therapy, and immunotherapy in cancer treatment.

Huang X, Zhang G, Tang T, Gao X, Liang T. Huang X, et al. Among authors: zhang g. Biochim Biophys Acta Rev Cancer. 2022 Mar;1877(2):188696. doi: 10.1016/j.bbcan.2022.188696. Epub 2022 Feb 12. Biochim Biophys Acta Rev Cancer. 2022. PMID: 35157980 Review.

3

Transcriptional control of pancreatic cancer immunosuppression by metabolic enzyme CD73 in a tumor-autonomous and -autocrine manner.

Tang T, Huang X, Lu M, Zhang G, Han X, Liang T. Tang T, et al. Among authors: zhang g. Nat Commun. 2023 Jun 8;14(1):3364. doi: 10.1038/s41467-023-38578-3. Nat Commun. 2023. PMID: 37291128 Free PMC article.

4

Reviving the role of MET in liver cancer therapy and vaccination: an autophagic perspective.

Huang X, Zhang G, Bai X, Liang T. Huang X, et al. Among authors: zhang g. Oncoimmunology. 2020 Sep 13;9(1):1818438. doi: 10.1080/2162402X.2020.1818438. Oncoimmunology. 2020. PMID: 33457099 Free PMC article. Review.

5

Cancer immunotherapeutic challenges from autophagy-immune checkpoint reciprocal regulation.

Zhang G, Chen Y, Huang X, Liang T. Zhang G, et al. Trends Cancer. 2024 Dec 19:S2405-8033(24)00253-X. doi: 10.1016/j.trecan.2024.11.001. Online ahead of print. Trends Cancer. 2024. PMID: 39706727 Review.

6

Split Cyclin-Dependent Kinase 4/6-Retinoblastoma 1 Axis in Pancreatic Cancer.

Huang X, Zhang G. Huang X, et al. Among authors: zhang g. Front Cell Dev Biol. 2020 Nov 12;8:602352. doi: 10.3389/fcell.2020.602352. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33282875 Free PMC article.

7

Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy.

Tang T, Huang X, Zhang G, Hong Z, Bai X, Liang T. Tang T, et al. Among authors: zhang g. Signal Transduct Target Ther. 2021 Feb 20;6(1):72. doi: 10.1038/s41392-020-00449-4. Signal Transduct Target Ther. 2021. PMID: 33608497 Free PMC article. Review.

8

Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine.

Huang X, Zhang G, Tang TY, Gao X, Liang TB. Huang X, et al. Among authors: zhang g. Mil Med Res. 2022 Oct 13;9(1):53. doi: 10.1186/s40779-022-00416-w. Mil Med Res. 2022. PMID: 36224645 Free PMC article. Review.

9

MiRNA-516a promotes bladder cancer metastasis by inhibiting MMP9 protein degradation via the AKT/FOXO3A/SMURF1 axis.

Chang Y, Jin H, Li H, Ma J, Zheng Z, Sun B, Lyu Y, Lin M, Zhao H, Shen L, Zhang R, Wu S, Lin W, Lu Y, Xie Q, Zhang G, Huang X, Huang H. Chang Y, et al. Among authors: zhang r, zhang g. Clin Transl Med. 2020 Dec;10(8):e263. doi: 10.1002/ctm2.263. Clin Transl Med. 2020. PMID: 33377649 Free PMC article.

10

Cancer environmental immunotherapy: starving tumor cell to death by targeting TGFB on immune cell.

Huang X, Zhang G, Liang T. Huang X, et al. Among authors: zhang g. J Immunother Cancer. 2021 Jun;9(6):e002823. doi: 10.1136/jitc-2021-002823. J Immunother Cancer. 2021. PMID: 34145032 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,261 results

Search Page

Filters